AWAG
GILD icon

ARS Wealth Advisors Group’s Gilead Sciences GILD Stock Holding History

ARS Wealth Advisors Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-57,733
Closed -$3.57M – 159
2022
Q2 		$3.57M Buy
+57,733
New +$3.57M 0.49% 62

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ARS Wealth Advisors Group's GILD Position: Q3 2022 in Review

ARS Wealth Advisors Group sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 57,733 shares — an estimated $3.57M sold.

ARS Wealth Advisors Group first reported a position in GILD in Q2 2022 and held it in 1 quarter. The position peaked at $3.57M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • ARS Wealth Advisors Group reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • ARS Wealth Advisors Group sold 57,733 Gilead Sciences shares in Q3 2022, an estimated $3.57M.
  • ARS Wealth Advisors Group first reported a position in Gilead Sciences in Q2 2022 and held it in 1 quarter.
  • ARS Wealth Advisors Group's Gilead Sciences position peaked at $3.57M in Q2 2022.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2022, filed 8 Nov 2022.